Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Anastasios Karadimitris, Niam Al-Mahdi et al.|Blood|2013Cited by 204
HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and MacrophagesMohammed Ghiboub, Wouter J. de Jonge, Jing Zhao et al.|Frontiers in Immunology|2020Cited by 71
Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future PerspectivesMohammed Ghiboub, Wouter J. de Jonge, Ahmed M I Elfiky et al.|Journal of Personalized Medicine|2021Cited by 24
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140Mohammed Ghiboub, Wouter J. de Jonge, Jan Köster et al.|BMC Biology|2022Cited by 24
Potent Anti-Myeloma Activity Of The Novel Bromodomain Inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Anastasios Karadimitris, Valentina S. Caputo et al.|Blood|2013Cited by 6